Isabell Remus | Global Head of Biosimilars
Sandoz
Isabell Remus is Global Head of Biosimilars at Sandoz, leading efforts to further expand biosimilar market leadership, support pipeline expansion, and increase access to essential biosimilar medicines. With over 20 years of pharmaceutical experience and 15 years at Sandoz, she brings expertise in commercialisation, market access, and the strategic opportunities reshaping the biosimilar landscape.
Her perspective is shaped by prior executive roles at Sandoz as Head of Commercial Europe, Head of Biopharmaceuticals & Specialty Business Europe, and Global Head of Product Strategy & Commercialization for Biosimilars and Oncology Injectables. In these positions, she launched therapies across multiple indications and developed local, regional and global strategies to expand market reach and patient access.
Before Sandoz, Isabell worked for Novartis and Procter & Gamble. She studied European Business Administration at Reutlingen University.
Appearances:
Festival of Biologics Day 1 @ 09:55
From policy to patients: The landscape reshaping global biosimilar access
Sandoz Global Head of Biosimilars, Isabell Remus, will explore the recent developments creating unprecedented opportunities to drive biosimilar development and uptake. From the latest regulatory shifts towards streamlining biosimilar development to the EU’s Critical Medicines Act, Isabell will explore what these movements mean for the biosimilar industry and patient access. She will discuss key opportunities to overcome barriers to access and how to build on current momentum as the global demand for affordable medicines continues to rise, delivering a definitive win for patients and the sustainability of healthcare systems worldwide
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events